Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrea Näke is active.

Publication


Featured researches published by Andrea Näke.


European Journal of Endocrinology | 2008

Daily insulin requirement of children and adolescents with type 1 diabetes: effect of age, gender, body mass index and mode of therapy.

Susanna Wiegand; Klemens Raile; Thomas Reinehr; Sabine E. Hofer; Andrea Näke; Wolfgang Rabl; Reinhard W. Holl

DESIGN The purpose of this study was to generate insulin dose (ID) percentiles for children and adolescents with type 1 diabetes mellitus (DM1) having the opportunity to assess this important parameter in relation to age and sex. METHODS Daily IDs per weight (ID/kg) were recorded in 22,177 patients with DM1 (3-25 years of age, DM1 duration of more than 2 years, 48% female) and ID percentiles (ID-Perc) were created statistically. The ID-Perc were compared between male and female, and between multiple insulin injection therapy (MIT) and continuous s.c. insulin infusion (CSII). A multivariate regression analysis was performed for ID in the third year of DM1 with ID/kg, body weight, age, gender, and insulin delivery regimen as variables. RESULTS The 50th ID-Perc (P50) varied among 0.67 IU/kg (age 3 years), 0.93 IU/kg (13 years), and 0.70 IU/kg (23 years) increasing from early childhood to adolescence and decreasing toward adulthood. Highest P50 ID was found at 12 years in females (0.94 IU/kg) and at 14 years in males (0.92 IU/kg). Using ICT, the ID was significantly higher compared with CSII (P50: 0.94 IU/kg versus 0.79 IU/kg at 13 years). In multivariate regression analysis, ID was significantly (P>0.001) associated with age, gender, and insulin delivery regime. CONCLUSION The ID-Perc were significantly different during various periods of childhood and were influenced by gender, body weight, and insulin injection regimes. Therefore, the presented data 1) provide evidence to interpret individual ID in children and adolescents with DM1 and 2) more specifically identify children with unusually high (insulin resistance and non-compliance) or low (MODY and persistent remission) insulin requirement.


Pediatric Diabetes | 2007

Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal–bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes

Thomas Danne; Jacob Råstam; Rainer Odendahl; Andrea Näke; Ulf Schimmel; Rüdiger Szczepanski; Johannes Moeller; Dorothea Deiss

Objectives:  Preprandial insulin injection in preschool children is complicated by irregular eating habits. Postprandial injection of rapid‐acting insulin analogs such as insulin aspart (IAsp) offers the convenience of adjusting insulin dose to match food consumed. This trial compared safety and efficacy – including parental treatment satisfaction – of two basal–bolus regimens [IAsp plus Neutral Protein Hagedorn (NPH) insulin vs. regular human insulin (HI) plus NPH] in preschool children with type 1 diabetes.


Pediatric Diabetes | 2009

Autonomic blood pressure control in children and adolescents with type 1 diabetes mellitus

Margit Krause; Heinz Rüdiger; Martin Bald; Andrea Näke; Ekkehart Paditz

Introduction:  Increased daytime blood pressure and reduced nocturnal dipping can already be found in children with type 1 diabetes mellitus. We hypothesized that impaired baroreflex sensitivity can cause this abnormal blood pressure behavior in children and adolescents with type 1 diabetes, reflecting an early stage of diabetic autonomic neuropathy.


European Journal of Endocrinology | 2012

Natural course of untreated microalbuminuria in children and adolescents with type 1 diabetes and the importance of diabetes duration and immigrant status: longitudinal analysis from the prospective nationwide German and Austrian diabetes survey DPV

Angela Galler; Holger Haberland; Andrea Näke; Sabine E. Hofer; Martin Holder; Klemens Raile; Reinhard W. Holl

OBJECTIVE To identify risk factors for the development and progression of untreated persistent microalbuminuria in children and adolescents with type 1 diabetes. DESIGN AND METHODS A total number of 683 children and adolescents with type 1 diabetes recruited from the prospective nationwide German and Austrian diabetes survey (DPV) were included in the analysis. Inclusion criteria were onset of type 1 diabetes under the age of 11 years, diabetes duration of more than 1 year and continuous follow-up over 5 years with at least two documented urine analyses per year. Subjects treated with angiotensin-converting enzyme inhibitors were excluded. Risk factors such as sex, body mass index SDS, diabetes duration, HbA1c, total cholesterol, HDL-cholesterol, LDL-cholesterol, systolic and diastolic blood pressure, and immigrant status were analysed by logistic regression. RESULTS At baseline (age 10.5 ± 0.1 years, diabetes duration 4.6 ± 2.4 years and HbA1c 7.4 ± 1.1%), 75.6% of children had normoalbuminuria, 15.7% had intermittent microalbuminuria, 8.6% had persistent microalbuminuria and 0.1% had macroalbuminuria. After a follow-up of 5 years, 59.4% of adolescents continued to have normoalbuminuria, 18.4% had progression, 15.2% had regression of microalbuminuria, and in 6.9% of the subjects, microalbuminuria remained unchanged. We found significant associations between persistent microalbuminuria at baseline and during each year of follow-up (P < 0.0001). Logistic regression analysis identified diabetes duration and immigrant status as significant factors for microalbuminuria (P = 0.009 and P = 0.009). CONCLUSIONS The survey in a real-world setting shows that diabetes duration and immigrant status are risk factors for the development and progression of untreated microalbuminuria in children and adolescents with type 1 diabetes.


Diabetes Care | 2015

Comparison of Glycemic and Metabolic Control in Youth With Type 1 Diabetes With and Without Antipsychotic Medication: Analysis From the Nationwide German/Austrian Diabetes Survey (DPV)

Angela Galler; Esther Bollow; Michael Meusers; Bela Bartus; Andrea Näke; Holger Haberland; Edith Schober; Reinhard W. Holl

OBJECTIVE The objective of this study was to explore metabolic risk factors and glycemic control in youth with type 1 diabetes treated with typical or atypical antipsychotics. RESEARCH DESIGN AND METHODS Data for 60,162 subjects with type 1 diabetes up to the age of 25 years registered in the nationwide German/Austrian Diabetes Survey were included in the analysis. BMI; HbA1c; treatment strategy; prevalence of hypertension, dyslipidemia, microalbuminuria, and retinopathy; frequency of hypoglycemia and diabetic ketoacidosis (DKA); and immigrant status among subjects treated with typical or atypical antipsychotics were compared with those without antipsychotic medication and analyzed by regression analysis. RESULTS A total of 291 subjects with type 1 diabetes (median diabetes duration 7.2 years) received antipsychotic medications (most commonly risperidone). Subjects treated with antipsychotics had a higher BMI (P = 0.004) and dyslipidemia was more frequent (P = 0.045) compared with subjects not receiving antipsychotic medication. Frequencies of severe hypoglycemia and DKA were significantly higher in subjects receiving antipsychotics (P < 0.001). The prevalences of hypertension, microalbuminuria, and retinopathy were not different. In subjects treated with typical antipsychotics, glycemic control did not differ compared with those who did not receive antipsychotic medications. By contrast, subjects treated with atypical antipsychotics had higher HbA1c levels (P = 0.022). CONCLUSIONS This analysis from a real-life survey demonstrated that subjects with antipsychotic medication had worse glycemic control and a higher rate of acute complications compared with those without antipsychotic medication. Health care teams caring for youth with type 1 diabetes taking antipsychotic medication need to know about these findings. We suggest monitoring metabolic risk factors as well as providing diabetes education about prevention of acute complications.


Journal of Child Neurology | 2009

Unusual radiological presentation of tuberous sclerosis complex with leptomeningeal angiomatosis associated with a hypomorphic mutation in the TSC2 gene.

Georgia Ramantani; Pascal Niggemann; Andrea Näke; Raimund Fahsold; Min Ae Lee-Kirsch

Tuberous sclerosis complex is an autosomal dominant disorder affecting primarily the central nervous system, skin, and kidney caused by mutations in the TSC1 and TSC2 genes. Diagnosis is established with the identification of various neurocutaneous symptoms and multiple organ system hamartomas. The authors report on a 9-year-old patient with episodes of vertigo and headache followed by full spontaneous recovery. There was no history of seizures, mental retardation, or other neurologic sequelae, and psychomotor development was normal. Magnetic resonance imaging revealed pial angiomatosis of the left cerebellum and calcifications in the left parieto-occipital lobe consistent with the diagnosis of Sturge-Weber syndrome. At the age of 13, multiple renal angiomyolipomas and a single hypomelanotic macule were found, and subsequent imaging revealed several cortical tuberi. The diagnosis was confirmed by sequence analysis, which identified a novel missense mutation p.Ala460Thr in exon 13 of the TSC2 gene. Thus, mild tuberous sclerosis due to a hypomorphic mutation in TSC2 may present with isolated leptomeningeal angiomatosis.


Annals of Neurology | 2018

Newborn screening: A disease-changing intervention for glutaric aciduria type 1: Newborn Screening for GA1

Nikolas Boy; Katharina Mengler; Eva Thimm; Katharina A. Schiergens; Thorsten Marquardt; Natalie Weinhold; Iris Marquardt; Anibh M. Das; Peter Freisinger; Sarah Catharina Grünert; Judith Vossbeck; Robert Steinfeld; Matthias R. Baumgartner; Skadi Beblo; Andrea Dieckmann; Andrea Näke; Martin Lindner; Jana Heringer; Georg F. Hoffmann; Chris Mühlhausen; Esther M. Maier; Regina Ensenauer; Sven F. Garbade; Stefan Kölker

Untreated individuals with glutaric aciduria type 1 (GA1) commonly present with a complex, predominantly dystonic movement disorder (MD) following acute or insidious onset striatal damage. Implementation of GA1 into newborn screening (NBS) programs has improved the short‐term outcome. It remains unclear, however, whether NBS changes the long‐term outcome and which variables are predictive.


Human Mutation | 2005

Identification of Novel GCK and HNF1A/TCF1 Mutations and Polymorphisms in German Families with Maturity-Onset Diabetes of the Young (MODY)

Dalia Toaima; Andrea Näke; Jutta Wendenburg; Kirsten Praedicow; Julia Rohayem; Kerstin Engel; Angela Galler; Manfred Gahr; Min Ae Lee-Kirsch


Kinder- und Jugendmedizin | 2005

Epidemiologie des Diabetes mellitus im Kindesalter: Daten aus dem Sächsischen Kinder-Diabetes-Register

Angela Galler; Thomas Kapellen; Thoralf Stange; Ulrike Rothe; Hildebrand Kunath; Andrea Näke; Christian Vogel; Wieland Kiess und Gesundheitsämter Aue; Dresden; Freiberg; Leipzig; Vogtlandkreis; Weißeritzkreis; Zittau und alle Teilnehmer


ESPE 2014 | 2014

Metabolic Consequences of Antipsychotic Medication in Youths with Type 1 Diabetes: Analysis from the Prospective Nationwide German and Austrian Diabetes Survey DPV

Angela Galler; Esther Molz; Michael Meusers; Bela Bartus; Andrea Näke; Holger Haberland; Edith Schober; Reinhard W. Holl

Collaboration


Dive into the Andrea Näke's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Holger Haberland

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Edith Schober

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Min Ae Lee-Kirsch

Dresden University of Technology

View shared research outputs
Top Co-Authors

Avatar

Sabine E. Hofer

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar

Anibh M. Das

Hannover Medical School

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge